For: | Al-Maghrabi J, Buhmeida A, Emam E, Syrjänen K, Sibiany A, Al-Qahtani M, Al-Ahwal M. Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma. World J Gastroenterol 2012; 18(15): 1793-1799 [PMID: 22553404 DOI: 10.3748/wjg.v18.i15.1793] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i15/1793.htm |
Number | Citing Articles |
1 |
Ling Peng, Yun Zhou, Yina Wang, Haibo Mou, Qiong Zhao, Syed A. Aziz. Prognostic Significance of COX-2 Immunohistochemical Expression in Colorectal Cancer: A Meta-Analysis of the Literature. PLoS ONE 2013; 8(3): e58891 doi: 10.1371/journal.pone.0058891
|
2 |
Archana Bharti Sonkar, Pranesh Kumar, Anand Kumar, Anurag Kumar Gautam, Abhishek Verma, Amita Singh, Umesh Kumar, Dinesh Kumar, Tarun Mahata, Bolay Bhattacharya, Amit K. Keshari, Biswanath Maity, Sudipta Saha. Vinpocetine mitigates DMH-induce pre-neoplastic colon damage in rats through inhibition of pro-inflammatory cytokines. International Immunopharmacology 2023; 119: 110236 doi: 10.1016/j.intimp.2023.110236
|
3 |
Haneen Al-Maghrabi. Survivin expression is associated with lymph node metastasis and short survival in patients with colorectal adenocarcinoma. International Journal of Clinical and Experimental Pathology 2024; 17(2): 39 doi: 10.62347/ZCUD7995
|
4 |
Abla Sayed Mahmoud, Ayesha Umair, Saleh Nasser Azzeghaiby, Fahad Hussain Alqahtani, Salah Hanouneh, Bassel Tarakji. Expression of Cyclooxygenase-2 (COX-2) in Colorectal Adenocarcinoma: an Immunohistochemical and Histopathological Study. Asian Pacific Journal of Cancer Prevention 2014; 15(16): 6787 doi: 10.7314/APJCP.2014.15.16.6787
|
5 |
Rania G. Roshdy, Eman M. Said. Expression and prognostic significance of cyclin D1 and cyclooxygenase-2 in colorectal carcinoma. Egyptian Journal of Pathology 2022; 42(1): 44 doi: 10.4103/egjp.egjp_10_22
|
6 |
Basim Al-Maghrabi, Wafaey Gomaa, Mohammed Abdelwahed, Jaudah Al-Maghrabi. Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis. Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/5026939
|
7 |
Gunes Coban, Fadime Aydin Kose, Petek Ballar Kirmizibayrak, Varol Pabuccuoglu. Synthesis, biological activity screening and molecular modeling study of acylaminoacetamide derivatives. Medicinal Chemistry Research 2015; 24(10): 3710 doi: 10.1007/s00044-015-1419-4
|
8 |
Honor J. Hugo, C. Saunders, R. G. Ramsay, E. W. Thompson. New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis. Journal of Mammary Gland Biology and Neoplasia 2015; 20(3-4): 109 doi: 10.1007/s10911-015-9333-4
|
9 |
Jaudah Al-Maghrabi, Eman Emam, Wafaey Gomaa, Moaath Saggaf, Abdelbaset Buhmeida, Mohammad Al-Qahtani, Mahmoud Al-Ahwal. c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1662-6
|
10 |
Qi-Bing Wu, Guo-Ping Sun. Expression of COX-2 and HER-2 in colorectal cancer and their correlation. World Journal of Gastroenterology 2015; 21(20): 6206-6214 doi: 10.3748/wjg.v21.i20.6206
|
11 |
Veronika Tupá, Slávka Drahošová, Marián Grendár, Marian Adamkov. Expression and association of carbonic anhydrase IX and cyclooxygenase-2 in colorectal cancer. Pathology - Research and Practice 2019; 215(4): 705 doi: 10.1016/j.prp.2019.01.012
|
12 |
Maqbool Ahmed, Azhar R Hussain, Abdul K. Siraj, Shahab Uddin, Nasser Al-Sanea, Fouad Al-Dayel, Mohammed Al-Assiri, Shaham Beg, Khawla S. Al-Kuraya. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0406-1
|
13 |
Nor Isnida Ismail, Iekhsan Othman, Faridah Abas, Nordin H. Lajis, Rakesh Naidu. Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer. International Journal of Molecular Sciences 2019; 20(10): 2454 doi: 10.3390/ijms20102454
|
14 |
Simon A. Ash, Donal J. Buggy. Does regional anaesthesia and analgesia or opioid analgesia influence recurrence after primary cancer surgery? An update of available evidence. Best Practice & Research Clinical Anaesthesiology 2013; 27(4): 441 doi: 10.1016/j.bpa.2013.10.005
|
15 |
Yousef Jalalabadi, Alireza Shirazi, Mohammad-Reza Ghavam-Nasiri, Seyed Amir Aledavood, Dariush Sardari, Bahram Memar, Soodabeh Shahidsales, Fatemeh VarshoeeTabrizi, Parvane Dehghan, Hassan Vosughiniya. Evaluating the expression of cyclooxygenase-2 enzyme by immunohistochemistry in normal and tumoral tissue before and after neoadjuvant chemoradiotherapy in patients with esophageal cancer in Khorasan Province. Journal of Cancer Research and Therapeutics 2018; 14(3): 509 doi: 10.4103/0973-1482.199428
|
16 |
Berska Joanna, Bugajska Jolanta, Grabowska Agnieszka, Hodorowicz-Zaniewska Diana, Sztefko Krystyna. Vitamin D, linoleic acid, arachidonic acid and COX-2 in colorectal cancer patients in relation to disease stage, tumour localisation and disease progression. Arab Journal of Gastroenterology 2019; 20(3): 121 doi: 10.1016/j.ajg.2019.05.007
|
17 |
Henrikas Pauzas, Ugne Gyvyte, Tadas Latkauskas, Laura Kairevice, Paulius Lizdenis, Saulius Svagzdys, Erika Birgiolaite, Irma Kuliaviene, Juozas Kupcinskas, Algimantas Tamelis. The Role of VEGFA, COX2, HUR and CUGBP2 in Predicting the Response to Neoadjuvant Therapy in Rectal Cancer Patients. Medicina 2020; 56(4): 192 doi: 10.3390/medicina56040192
|
18 |
Katie Herbert, Rachel Kerr, David J. Kerr, David N. Church. Are NSAIDs Coming Back to Colorectal Cancer Therapy or Not?. Current Colorectal Cancer Reports 2014; 10(4): 363 doi: 10.1007/s11888-014-0247-0
|
19 |
Yasutaka Kato, Hiroshi Nishihara, Hiromi Mohri, Hiromi Kanno, Hiroyuki Kobayashi, Taichi Kimura, Mishie Tanino, Shunsuke Terasaka, Shinya Tanaka. Clinicopathological evaluation of cyclooxygenase-2 expression in meningioma: immunohistochemical analysis of 76 cases of low and high-grade meningioma. Brain Tumor Pathology 2014; 31(1): 23 doi: 10.1007/s10014-012-0127-8
|
20 |
Melissa Kang, Temitope O. Keku. Impact of Energy Balance on Cancer Disparities. 2014; : 131 doi: 10.1007/978-3-319-06103-0_7
|